ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,725,000 | +68.5% | 101,500 | +1.5% | 0.33% | +30.7% |
| Q4 2018 | $1,617,000 | +7.4% | 100,000 | +37.9% | 0.25% | +78.9% |
| Q3 2018 | $1,505,000 | +97.0% | 72,500 | +45.0% | 0.14% | +89.3% |
| Q2 2018 | $764,000 | -32.0% | 50,000 | 0.0% | 0.08% | -35.3% |
| Q1 2018 | $1,124,000 | -25.4% | 50,000 | 0.0% | 0.12% | -40.5% |
| Q4 2017 | $1,506,000 | -20.1% | 50,000 | 0.0% | 0.20% | -21.4% |
| Q3 2017 | $1,884,000 | +32.5% | 50,000 | -2.0% | 0.25% | +32.6% |
| Q2 2017 | $1,422,000 | -17.3% | 51,000 | +2.0% | 0.19% | -16.5% |
| Q1 2017 | $1,719,000 | +19.2% | 50,000 | 0.0% | 0.22% | +23.1% |
| Q4 2016 | $1,442,000 | -9.4% | 50,000 | 0.0% | 0.18% | -14.2% |
| Q3 2016 | $1,591,000 | -2.0% | 50,000 | 0.0% | 0.21% | +2.9% |
| Q2 2016 | $1,623,000 | +9.5% | 50,000 | -5.7% | 0.21% | +13.2% |
| Q1 2016 | $1,482,000 | -21.5% | 53,000 | 0.0% | 0.18% | -15.0% |
| Q4 2015 | $1,889,000 | – | 53,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |